Sam Bankman-Fried isn't going down without a fight. The disgraced FTX founder on Tuesday pleaded not guilty on all counts, including multiple charges of fraud and conspiracy.
Bankman-Fried, 30, is going a different route than his co-executives at FTX: Gary Wang, co-founder of FTX, and Caroline Ellison, CEO of Alameda Research, have both pleaded guilty.
Indeed, there is widespread consensus that FTX's leadership engaged in criminal activity. Even current CEO John J. Ray III has described the situation as "old-fashioned embezzlement."
The U.S. attorney of the Southern District of New York filed the charges in December, along with parallel actions from the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC).
Bankman-Fried is currently out of prison on a $250 million bail bond.
Judge Lewis A. Kaplan has tentatively set a trial date of October 2nd.
Gift cards make great stocking stuffers — just as long as you don't stuff them in a drawer and forget about them after the holidays.
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bristol Myers Squibb agreed to buy schizophrenia drug maker Karuna Therapeutics in a $14 billion deal.
Supermarket chain Ralphs is facing a new lawsuit from the state of California.
Shake Shack is giving out free fried chicken sandwiches, bacon cheese fries and milkshakes nationwide.
The IRS is announcing a voluntary disclosure program.
Lionsgate announced its studio division is going to spin off in a merger with Screaming Eagle Acquisition Corp., which is a special purpose acquisition company.
A new report suggests that it's getting more difficult for an average American to afford a home.
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Tesla is reportedly moving forward with its plan to make energy shortage storage batteries in China.
